Sign in

CIK 0001400118 · <br>Emerging growth company

Sagimet Biosciences Inc.

Sign in to watch
Ticker
SGMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
205991472
Phone
(650) 561-8600
Business address
950 TOWER LANE, STE 1500, FOSTER CITY, CA, 94404
Former names
3-V Biosciences, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-07-21 Martins Eduardo Bruno Chief Medical Officer Sale −8,277 $9.13 $76K 106,936
2025-07-21 Rozek Elizabeth General Counsel and CCO Sale −10,780 $9.13 $98K 183,726
2025-06-09 Walbert Timothy P Director Grant or award · Stock Option (Right to Buy) +32,250 32,250
2025-06-09 SEIDENBERG BETH C Director Grant or award · Stock Option (Right to Buy) +32,250 32,250
2025-06-09 Phillips Anne M. Director Grant or award · Stock Option (Right to Buy) +27,268 27,268
2025-06-09 Kemble George Director Grant or award · Stock Option (Right to Buy) +32,250 32,250
2025-06-09 Jarrett Jennifer Director Grant or award · Stock Option (Right to Buy) +27,268 27,268
2025-06-09 Hoelscher Paul W. Director Grant or award · Stock Option (Right to Buy) +32,250 32,250
2025-06-09 GRAMMER ELIZABETH A Director Grant or award · Stock Option (Right to Buy) +32,250 32,250
2025-06-06 SEIDENBERG BETH C Director Grant or award · Stock Option (Right to Buy) +28,522 28,522
2025-02-06 Martins Eduardo Bruno Chief Medical Officer Grant or award +34,000 115,213
2025-02-06 Martins Eduardo Bruno Chief Medical Officer Grant or award · Stock Option (Right to Buy) +138,000 138,000
2025-02-06 Happel David President & CEO Grant or award +116,000 755,200
2025-02-06 Happel David President & CEO Grant or award · Stock Option (Right to Buy) +472,000 472,000
2025-02-06 Rozek Elizabeth General Counsel and CCO Grant or award +34,000 194,506
2025-02-06 Rozek Elizabeth General Counsel and CCO Grant or award · Stock Option (Right to Buy) +138,000 138,000
2025-02-06 Chauche Thierry Chief Financial Officer Grant or award +17,000 17,000
2025-02-06 Chauche Thierry Chief Financial Officer Grant or award · Stock Option (Right to Buy) +69,000 69,000
2024-08-01 Jarrett Jennifer Director Grant or award · Stock Option (Right to Buy) +113,895 113,895
2024-08-01 Phillips Anne M. Director Grant or award · Stock Option (Right to Buy) +113,895 113,895

Page 3 of 10 · 194 trades